US SEC Filings Daily Market Digest — February 16, 2026

17-02-2026

LOUISIANA-PACIFIC CORP filed a Form 8-K on 2026-02-17 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or any financial metrics are disclosed. This appears to be a routine leadership disclosure with no quantified positive or negative impacts provided.

17-02-2026

Republic Services, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001060391-26-000072, size: 11 MB), reporting under Item 5.03 regarding amendments to Articles of Incorporation or Bylaws, or a change in fiscal year. No specific details on the nature, scope, or implications of the amendments or changes are disclosed in the filing summary. No financial metrics, transaction values, or other quantitative data are mentioned.

17-02-2026

MGP Ingredients Inc filed an 8-K on February 17, 2026 (AccNo: 0000835011-26-000006), disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Specific details including names, titles, reasons for changes, or any quantitative impacts are NOT_DISCLOSED. No positive or negative metrics, financial data, or further context provided.

17-02-2026

CAPITAL ONE FINANCIAL CORP filed an 8-K on February 17, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary. This is a multi-item voluntary filing with no mentioned positive or negative performance indicators.

17-02-2026

17-02-2026

Greenpro Capital Corp. filed an 8-K on February 17, 2026, under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific details on the agreement terms, transaction value, financial impacts, or other metrics are disclosed.

17-02-2026

Allegion plc filed an 8-K on February 17, 2026 (AccNo: 0001579241-26-000006), reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed quantitative data available.

17-02-2026

Honeywell International Inc filed a Form 8-K on February 17, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves a voluntary disclosure to comply with Regulation FD, with exhibits attached, but no specific financial metrics, transactions, or performance data are detailed. No positive or negative metrics are disclosed, providing only structural filing information.

17-02-2026

MODINE MANUFACTURING CO filed an 8-K on February 17, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transactions, period-over-period comparisons, or other quantitative data are disclosed in the provided filing information. The filing size is 5 MB, but contents of the disclosure and exhibits are NOT_DISCLOSED.

• ·AccNo: 0001104659-26-015568
• ·Filing size: 5 MB

17-02-2026

DAILY JOURNAL CORP filed an 8-K on February 17, 2026 (AccNo: 0001437749-26-004210), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing information. This is a standard voluntary disclosure of financial results with attached exhibits.

17-02-2026

The company filed an 8-K on February 17, 2026 (AccNo: 0001104659-26-015557), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item, general filing of 2 MB size with no specific details on the nature of other events, transaction values, financial metrics, or exhibits provided. No quantitative data, named entities, or directional impacts are disclosed.

17-02-2026

Portland General Electric Co /OR/ filed a Form 8-K on 2026-02-17 reporting multiple material items: entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing likely combining earnings release with new agreement and financing details. Specific transaction values, financial metrics, period-over-period changes, guidance, or impacts are NOT_DISCLOSED.

17-02-2026

EKSO Bionics Holdings, Inc. filed a multi-item Form 8-K on February 17, 2026, disclosing events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.01 (Changes in Control of Registrant), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), 5.03 (Amendments to Articles of Incorporation or Bylaws), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative impacts are disclosed. The combination of control changes, equity sales, and governance modifications suggests potential strategic shifts, dilution risks, and operational updates without further details provided.

17-02-2026

National Energy Services Reunited Corp. filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-006872), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, margins, or other metrics are provided in the filing summary. No positive or negative performance indicators, guidance, or comparisons are detailed.

17-02-2026

Ralliant Corp filed an 8-K on February 17, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing summary. The filing size is 4 MB, indicating potential attachments such as exhibits.

17-02-2026

Cineverse Corp. disclosed entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), representing a key strategic transaction; however, it also created a direct financial obligation (Item 2.03) and involved unregistered sales of equity securities (Item 3.02), potentially introducing leverage and dilution risks. Regulation FD disclosure was provided (Item 7.01) with financial statements and exhibits (Item 9.01). No specific deal terms, parties, values, or financial metrics are disclosed.

17-02-2026

Armada Hoffler Properties, Inc. filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results, but specific metrics such as revenue, earnings, or guidance are NOT_DISCLOSED. No period-over-period comparisons, positive or negative changes, or other quantitative details are provided in the filing information.

17-02-2026

Leidos Holdings, Inc. filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or quantitative data are disclosed in the provided filing information. This is a standard multi-item earnings-related disclosure with no directional performance indicators available.

17-02-2026

Hyatt Hotels Corp filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names of individuals involved, appointment or resignation status, reasons for the change, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events were mentioned in the provided filing information.

17-02-2026

JFB Construction Holdings filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-006871), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for change, or any financial metrics are disclosed. Sector information is not specified.

• ·Filing date: 2026-02-17
• ·Accession Number: 0001493152-26-006871
• ·File size: 208 KB
• ·Event type: Officer Change

17-02-2026

Sonoco Products Co filed an 8-K on February 17, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are detailed in the provided filing information. This represents a standard earnings-related disclosure without extracted numerical data.

17-02-2026

nVent Electric plc filed an 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, transaction size, parties, financial impacts, or quantitative metrics are provided.

17-02-2026

Datavault AI Inc. filed a Form 8-K on February 17, 2026, disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This multi-item filing announces financial results with attached exhibits. No specific revenue, earnings, comparisons, guidance, or other quantitative metrics are disclosed.

17-02-2026

IDEAYA Biosciences, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-052741, Size: 344 KB), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or quantitative financial metrics are mentioned in the filing description. This is a standard financial results announcement with no disclosed positive or negative performance indicators.

17-02-2026

Matthews International Corp filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are disclosed.

17-02-2026

CEA Industries Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001493152-26-006862, Size: 280 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed. No quantitative metrics, financial impacts, or strategic information are provided.

17-02-2026

SPACSphere Acquisition Corp. filed an 8-K on 2026-02-17 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a merger/acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, or strategic rationale were explicitly stated. Sector not specified, limiting assessment of market implications.

• ·Accession Number: 0001829126-26-001360
• ·File Size: 467 KB

17-02-2026

BioRestorative Therapies, Inc. filed an 8-K on 2026-02-17 reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

17-02-2026

Proem Acquisition Corp. I filed an 8-K on 2026-02-17 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition. The filing also covers unregistered sales of equity securities (Item 3.02), departures/elections of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific deal parties, structure, valuation, financial metrics, or impacts are disclosed.

17-02-2026

TG-17, Inc. filed a Form 8-K on February 17, 2026, under Item 1.01 disclosing entry into a material definitive agreement and Item 9.01 providing financial statements and exhibits. No details on the agreement's nature, counterparties, terms, value, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics or period-over-period comparisons provided.

17-02-2026

Applied Digital Corp. filed an 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No quantitative details, financial impacts, positive or negative metrics, or period-over-period comparisons are provided in the available information.

17-02-2026

Accuray Inc filed a Form 8-K on February 17, 2026 (AccNo: 0001437749-26-004223, Size: 3 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the Regulation FD disclosure, financial statements, exhibits, transactions, metrics, or events are provided in the filing summary. Critical financial or operational data is NOT_DISCLOSED.

17-02-2026

Bioxytran, Inc. filed an 8-K on 2026-02-17 disclosing Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, events, financial impacts, or quantitative metrics were provided in the filing summary. No positive or negative metrics were mentioned.

17-02-2026

Artificial Intelligence Technology Solutions Inc. filed an 8-K on February 17, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of any exhibits are provided. No quantitative metrics, positive or negative changes, or financial impacts are mentioned.

17-02-2026

17-02-2026

SOMNIGROUP INTERNATIONAL INC. filed an 8-K on February 17, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, transaction values, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item filing focused on financial updates and exhibits.

17-02-2026

InfuSystem Holdings, Inc. filed a Form 8-K on February 17, 2026, under Item 7.01 Regulation FD Disclosure. This voluntary filing discloses material non-public information to comply with Regulation FD requirements. No specific financial metrics, transactions, events, or quantitative data are detailed in the provided filing information.

17-02-2026

CNH Industrial N.V. filed an 8-K on 2026-02-17 reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 8.01 (Other Events), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details. This is a multi-item voluntary disclosure typical for earnings releases.

17-02-2026

AG Mortgage Investment Trust, Inc. filed a Form 8-K on February 17, 2026, reporting solely under Item 8.01 Other Events. No specific details on the nature of the event, financial metrics, transactions, or impacts are disclosed. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

17-02-2026

COMPASS Pathways plc filed an 8-K on February 17, 2026, disclosing information under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, financial metrics, transactions, or events are mentioned in the provided filing summary. Critical content from the items and exhibits is missing.

17-02-2026

Herc Holdings Inc filed a Form 8-K on 2026-02-17 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item earnings-related filing, but specific revenue, earnings, guidance, or other quantitative financial metrics are NOT_DISCLOSED. No positive or negative performance indicators, period-over-period comparisons, or material events with dollar values were detailed in the provided filing information.

17-02-2026

TE Connectivity plc filed an 8-K on February 17, 2026, reporting under Item 1.01 the entry into a material definitive agreement, under Item 1.02 the termination of a material definitive agreement, and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, financial impacts, positive or negative metrics, or directional changes were disclosed.

17-02-2026

Medtronic plc filed a Form 8-K on February 17, 2026 (AccNo: 0001628280-26-008300), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with a file size of 1 MB indicating potential detailed exhibits.

17-02-2026

Waystar Holding Corp. filed an 8-K on February 17, 2026 (AccNo: 0001990354-26-000010), reporting under Item 2.02 Results of Operations and Financial Condition, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative details available for analysis.

17-02-2026

Trinseo PLC filed a Form 8-K on February 17, 2026 (AccNo: 0001104659-26-015648), reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, financial impacts, or performance metrics disclosed in the provided information. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

17-02-2026

DTE Energy Co filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, revenue, earnings, guidance, or other quantitative data were explicitly stated in the provided filing details. This appears to be a standard earnings-related disclosure without detailed results in the excerpt.

17-02-2026

Kennedy-Wilson Holdings, Inc. filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the nature of the agreement, events, or exhibits are provided in the filing summary. No quantitative financial metrics, period-over-period comparisons, or directional impacts are mentioned.

17-02-2026

Labcorp Holdings Inc. filed an 8-K on February 17, 2026 (AccNo: 0000920148-26-000098), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.

17-02-2026

Trinity Industries Inc filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 notes financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, or impacts are disclosed.

17-02-2026

WESCO INTERNATIONAL INC filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individuals involved, reasons for the change, or any financial metrics are disclosed. This appears to be a routine governance disclosure with no quantified impacts mentioned.

17-02-2026

17-02-2026

Genuine Parts Co filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-053013), reporting results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases, with no positive or negative performance details available.

17-02-2026

Krystal Biotech, Inc. filed an 8-K on February 17, 2026, under Item 2.02 to disclose results of operations and financial condition. No specific revenue, earnings, balance sheet impacts, guidance, or quantitative metrics were provided in the filing details. This represents a standard voluntary earnings-related disclosure with no directional financial data available.

17-02-2026

Neogenomics Inc filed an 8-K on February 17, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are mentioned. This is an informational earnings-related disclosure with no detailed performance data provided.

17-02-2026

Shutterstock, Inc. filed a Form 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or other quantitative metrics are provided in the filing description. No positive or negative performance indicators, period-over-period changes, or strategic details are mentioned.

17-02-2026

Axsome Therapeutics, Inc. filed a Form 8-K on February 17, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing, but specific details of the other event, transaction, financial statements, or exhibits are NOT_DISCLOSED. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

17-02-2026

Vulcan Materials Company filed an 8-K on February 17, 2026 (AccNo: 0001140361-26-005605), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely related to earnings or operational updates, but no specific financial metrics, positive or negative changes, guidance, or transaction details are disclosed in the provided information. All quantitative data and performance comparisons remain NOT_DISCLOSED.

17-02-2026

Knife River Corp filed a Form 8-K on February 17, 2026 (AccNo: 0001628280-26-008306), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This multi-item filing pertains to financial results with no specific revenue, earnings, margins, or period-over-period metrics provided. Detailed quantitative data, guidance, or performance variances are NOT_DISCLOSED.

17-02-2026

Fluor Corp filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed quantitative data available.

17-02-2026

AIR INDUSTRIES GROUP filed a Form 8-K on February 17, 2026, reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with both mandatory (Items 1.01, 3.02) and voluntary (Item 7.01) disclosures. No quantitative details such as transaction values, share counts, financial impacts, or strategic context are disclosed.

17-02-2026

Science Applications International Corp filed an 8-K on 2026-02-17 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or market impacts are mentioned.

17-02-2026

USA Compression Partners, LP filed an 8-K on February 17, 2026 (AccNo: 0001522727-26-000010), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard multi-item earnings-related disclosure without quantified financial impacts available.

17-02-2026

Crown PropTech Acquisitions filed an 8-K on 2026-02-17 (AccNo: 0001213900-26-016858) disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger/acquisition. Additional disclosures include Regulation FD under Item 7.01, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific deal structure, parties, valuation, metrics, or performance details are disclosed.

17-02-2026

Coronado Global Resources Inc. filed an 8-K on February 17, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the disclosure content, financial statements, exhibits, or any metrics are provided in the filing summary. This appears to be a voluntary disclosure of material information pursuant to Regulation FD.

17-02-2026

Donnelley Financial Solutions, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-052959), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are disclosed in the provided filing description. This appears to be a standard earnings-related disclosure without detailed performance data available.

17-02-2026

CEVA INC filed an 8-K on February 17, 2026 (AccNo: 0001437749-26-004232), reporting Results of Operations and Financial Condition under Item 2.02 and providing Financial Statements and Exhibits under Item 9.01. This constitutes a multi-item filing for financial results disclosure. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information.

• ·Sector: not specified
• ·Source: us_sec
• ·File size: 548 KB

17-02-2026

SunocoCorp LLC filed an 8-K on February 17, 2026, under Item 2.02 for Results of Operations and Financial Condition, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the provided filing information. This is an informational earnings-related disclosure without quantified metrics.

17-02-2026

Valmont Industries Inc filed a Form 8-K on 2026-02-17 under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned in the provided filing details. This is a standard voluntary earnings disclosure with no quantitative metrics extracted.

17-02-2026

Twist Bioscience Corp filed an 8-K on February 17, 2026, reporting unregistered sales of equity securities under Item 3.02 and other events under Item 8.01, accompanied by financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are disclosed. This is a multi-item informational filing with no specified positive or negative metrics.

17-02-2026

Sunoco LP filed an 8-K on February 17, 2026, disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are mentioned in the provided filing summary. This is a multi-item filing typical for earnings releases, but detailed quantitative data is NOT_DISCLOSED.

17-02-2026

Kyndryl Holdings, Inc. filed an 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected (e.g., CEO, CFO), names, reasons for changes, timing, or impacts are provided in the filing summary. No quantitative data, financial metrics, or scheduled events are mentioned.

17-02-2026

Builders FirstSource, Inc. filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, period-over-period changes, or other financial metrics are disclosed in the provided filing information. No positive or negative performance details, guidance, or comparisons are available.

17-02-2026

Cyclerion Therapeutics, Inc. filed a Form 8-K on February 17, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with voluntary disclosure under Reg FD, likely including attached exhibits such as a press release, but no specific details, financial metrics, transactions, or events are disclosed in the provided filing information.

17-02-2026

APi Group Corp filed an 8-K on February 17, 2026 (AccNo: 0001628280-26-008320), specifically under Item 2.02 for Results of Operations and Financial Condition. No quantitative financial metrics, period-over-period comparisons, guidance, or other detailed results are explicitly stated in the provided filing information. Sector is not specified.

17-02-2026

M3-Brigade Acquisition V Corp. filed an 8-K on 2026-02-17 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific merger/acquisition details, transaction values, parties involved, financial metrics, or period-over-period comparisons were explicitly stated in the filing information provided. Sector was not specified.

17-02-2026

Hillman Solutions Corp. filed an 8-K on February 17, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were detailed in the provided filing information. No positive, negative, or flat performance metrics were mentioned.

17-02-2026

SideChannel, Inc. filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, vote outcomes, or quantitative data are disclosed in the provided filing information. This multi-item filing combines earnings-related disclosure with shareholder meeting results.

17-02-2026

Soluna Holdings, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001493152-26-006929, Size: 272 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the nature of the exhibits are provided in the filing summary. No financial metrics, transactions, or other quantitative data are disclosed.

17-02-2026

WATSCO INC filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-053048), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, guidance, or other quantitative metrics. No positive or negative performance indicators, period-over-period changes, or segment details are mentioned.

17-02-2026

Cytokinetics Inc filed a Form 8-K on February 17, 2026, under Item 8.01 Other Events. No specific details regarding the nature of the other event, financial impacts, quantitative metrics, or scheduled events are disclosed in the provided filing information. This is a single-item voluntary disclosure with all transaction, performance, and strategic details NOT_DISCLOSED.

17-02-2026

MAINZ BIOMED N.V. filed a multi-item Form 8-K on February 17, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departure/election of directors or officers and compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including transaction values, share counts, financial impacts, dollar amounts, or quantitative metrics are NOT_DISCLOSED. The combination of potential strategic agreement alongside equity issuances and rights changes suggests mixed implications, but lacks quantification for assessment.

17-02-2026

Columbia Financial, Inc. filed an 8-K on February 17, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or impacts are provided in the available information. This is a required SEC disclosure for material leadership events, but lacks quantitative or qualitative context.

17-02-2026

FiscalNote Holdings, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-053083, Size: 183 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the Regulation FD disclosure content, financial statements, exhibits, transactions, metrics, or events are provided in the filing summary. This appears to be a multi-item informational filing with no disclosed quantitative data or directional impacts.

17-02-2026

Disc Medicine, Inc. filed a Form 8-K on February 17, 2026, under Item 7.01 Regulation FD Disclosure, indicating voluntary release of material nonpublic information, and Item 9.01 Financial Statements and Exhibits, likely attaching related materials such as a press release. No specific financial metrics, transactions, events, or quantitative data are disclosed in the provided filing information. Details of the disclosure content remain NOT_DISCLOSED.

17-02-2026

Energy Transfer LP filed a Form 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard earnings-related disclosure, but no specific financial metrics, period-over-period comparisons, or performance details (positive, negative, or flat) are provided in the filing summary. All quantitative data and operational details are NOT_DISCLOSED.

17-02-2026

Churchill Capital Corp X/Cayman filed an 8-K on February 17, 2026, disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), marking a change in shell company status (Item 5.06). The filing also covers unregistered sales of equity securities (Item 3.02), material modifications to security holder rights (Item 3.03), changes in control (Item 5.01), director and officer changes including compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), and amendments to the code of ethics (Item 5.05). No specific financial metrics, deal values, or performance comparisons are disclosed.

17-02-2026

News Corp filed an 8-K on February 17, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed. No quantitative metrics, positive or negative changes, or period-over-period comparisons are provided in the filing summary.

17-02-2026

Blue Bird Corp filed an 8-K on 2026-02-17 disclosing Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics are provided in the filing summary. No positive, negative, or flat performance metrics are disclosed.

17-02-2026

Danaher Corp filed a Form 8-K on February 17, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the events, transactions, financial metrics, or exhibits are provided in the filing summary.

17-02-2026

Tianci International, Inc. filed an 8-K on February 17, 2026, disclosing Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters submitted, vote outcomes, shareholder turnout, or proposals are provided in the filing summary. This is an informational filing with no financial metrics or quantitative data disclosed.

17-02-2026

CNX Resources Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-053115, size: 219 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of material information to comply with Regulation FD, with exhibits attached. No quantitative data, financial metrics, transactions, or specific events are disclosed in the provided filing information.

17-02-2026

Cognex Corp filed an 8-K on February 17, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 7.01 covers Regulation FD Disclosure, and Item 9.01 lists financial statements and exhibits. Specific details including key position affected, appointment or resignation status, reasons for change, timing, names, and any quantitative data are NOT_DISCLOSED.

17-02-2026

XFLH Capital Corp filed a Form 8-K on February 17, 2026, reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This multi-item filing signals significant corporate actions including a material agreement and potential equity dilution, but no specific transaction values, financial impacts, or further details are disclosed. No positive or negative metrics are provided, resulting in informational disclosure without directional bias.

17-02-2026

FONAR CORP filed an 8-K on February 17, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing summary. This is an informational filing on financial results with no detailed performance data available.

17-02-2026

TLGY ACQUISITION CORP filed an 8-K on 2026-02-17 under Item 8.01 Other Events related to a Merger/Acquisition event. No specific deal structure, parties involved, valuation, terms, financial metrics, or other quantitative details are disclosed in the provided filing metadata. Sector is not specified.

17-02-2026

NeuroOne Medical Technologies Corp filed an 8-K on February 17, 2026 (AccNo: 0001213900-26-016912), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

17-02-2026

Intellinetics, Inc. filed a Form 8-K on 2026-02-17 disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing for most items, but no specific details on the agreement, obligation size, officer changes, dollar values, strategic rationale, or quantitative impacts are provided. No positive, negative, or flat metrics are mentioned.

17-02-2026

Telomir Pharmaceuticals, Inc. filed an 8-K on February 17, 2026, reporting under Item 8.01 Other Events. No specific details, financial metrics, transactions, or other quantitative data are disclosed in the provided filing information. The filing has AccNo 0001493152-26-006937 and size 207 KB.

17-02-2026

ASP Isotopes Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001477932-26-000834, size: 161 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on voluntary disclosure of potentially material non-public information with attached exhibits. No financial metrics, transactions, quantitative data, or operational details are explicitly stated in the filing summary.

17-02-2026

1606 CORP. filed an 8-K on February 17, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with a document size of 156 KB (AccNo: 0001477932-26-000833). No specific financial metrics, transaction details, or performance data (positive, negative, or flat) are disclosed in the provided filing information.

17-02-2026

Playtika Holding Corp. filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 references financial statements and exhibits. No specific transaction details, values, or impacts are disclosed.

17-02-2026

Strategy Inc filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-053105), reporting under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). No specific details regarding the disclosures, financial metrics, transactions, or events are provided in the filing summary. This is a multi-item filing with no quantitative data or directional impacts disclosed.

17-02-2026

FRANKLIN ELECTRIC CO INC filed an 8-K on 2026-02-17 under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, or period-over-period comparisons are mentioned. This appears to be a standard voluntary earnings-related disclosure with attached exhibits.

• ·Accession Number: 0000038725-26-000002
• ·File Size: 451 KB

17-02-2026

Graham Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-053140), reporting under Item 5.02 on departure of directors or certain officers, election/appointment of directors/officers, and compensatory arrangements; Item 7.01 on Regulation FD disclosure; and Item 9.01 on financial statements and exhibits. Specific details including officer names, positions, reasons for change, timing, or any financial metrics are NOT_DISCLOSED. No quantitative data, performance comparisons, or scheduled events are mentioned.

17-02-2026

Pangaea Logistics Solutions Ltd. filed an 8-K on February 17, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific event details, financial metrics, transactions, or comparisons are provided in the filing summary. No positive or negative metrics are mentioned.

17-02-2026

Cogent Biosciences, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-053131), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were mentioned. This is a standard financial results announcement without quantified metrics provided.

17-02-2026

Invech Holdings, Inc. filed a Form 8-K on February 17, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.01 (Changes in Control of Registrant), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), and 9.01 (Financial Statements and Exhibits). No specific details on transaction values, parties involved, financial impacts, or changes are provided in the filing summary. This multi-item filing indicates a potentially transformative corporate event such as a merger or acquisition leading to control changes, but lacks quantitative data for assessment.

17-02-2026

Turn Therapeutics Inc. filed a Form 8-K on February 17, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or quantitative data are explicitly stated in the provided filing summary. The filing size is 212 KB with Accession Number 0001213900-26-016916.

17-02-2026

Cingulate Inc. filed an 8-K on 2026-02-17 disclosing events under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details including affected positions, names, appointment or resignation status, reasons, and any financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or scheduled events were mentioned.

17-02-2026

Gemini Space Station, Inc. filed an 8-K on 2026-02-17 disclosing results of operations and financial condition under Item 2.02 and an officer or director change, including potential compensatory arrangements, under Item 5.02. No specific details such as the key position affected, appointment or resignation status, reasons for the change, board impacts, financial metrics, or quantitative data are provided. The filing is informational with no disclosed positive or negative performance indicators.

17-02-2026

Conagra Brands Inc. filed an 8-K on February 17, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, guidance, or scheduled events are detailed in the filing summary provided. This is a multi-item filing likely involving voluntary disclosure of material non-public information with attached exhibits.

17-02-2026

LGI Homes, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001580670-26-000007, Size: 493 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific revenue, earnings, guidance, metrics, period-over-period changes, or other quantitative details are mentioned in the provided filing information.

17-02-2026

Cousins Properties Inc filed an 8-K on February 17, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events or the nature of the attached financial statements and exhibits are disclosed in the provided filing summary. This appears to be an informational disclosure without quantified financial impacts.

17-02-2026

CNS Pharmaceuticals, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001683168-26-001066), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, timing, or any compensatory arrangements are disclosed. No quantitative metrics, financial data, or performance comparisons are provided.

17-02-2026

MaxLinear, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, appointment or resignation, reasons, or quantitative impacts are disclosed.

• ·Event date: February 17, 2026
• ·Filing accession number: 0001288469-26-000017
• ·File size: 210 KB

17-02-2026

Glimpse Group, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-006950), reporting under Item 2.02 Results of Operations and Financial Condition, with Item 9.01 Financial Statements and Exhibits. This is a multi-item filing disclosing financial results, but no specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance are provided in the filing description. Sector is not specified.

17-02-2026

ITRON, INC. filed a Form 8-K on February 17, 2026 (AccNo: 0001171843-26-000850, Size: 637 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed financial data available.

• ·File size: 637 KB
• ·Sector: NOT_DISCLOSED

17-02-2026

Moleculin Biotech, Inc. filed an 8-K on February 17, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary provided. This appears to be a multi-item informational filing with attached exhibits.

17-02-2026

Investors Title Co filed an 8-K on February 17, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative financial metrics were explicitly stated in the provided filing details. This appears to be a standard voluntary earnings-related disclosure without detailed performance data.

17-02-2026

D. Boral Acquisition I Corp. filed an 8-K on 2026-02-17 announcing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, departure/election/appointment of directors/officers and compensatory arrangements under Item 5.02, amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on deal parties, structure, valuation, synergies, or financial metrics are disclosed. No positive or negative performance metrics are provided in the filing summary.

17-02-2026

Cooper-Standard Holdings Inc. filed an 8-K on February 17, 2026, reporting Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the filing summary. This is an informational filing with no quantified financial metrics, positive or negative changes reported.

17-02-2026

Bowman Consulting Group Ltd. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, timing, or any quantitative financial metrics are disclosed. This appears to be a routine governance disclosure without additional performance data.

17-02-2026

Signing Day Sports, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001213900-26-016927, size: 264 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on voluntary disclosure of potentially material information with attached exhibits. No specific financial metrics, transactions, or quantitative data are disclosed.

17-02-2026

Outlook Therapeutics, Inc. filed an 8-K on 2026-02-17 reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are explicitly stated in the filing summary provided.

17-02-2026

Nukkleus Inc. filed an 8-K on 2026-02-17 announcing the completion of an acquisition or disposition of assets under Item 2.01, with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on deal parties, structure, valuation, synergies, or financial impacts were disclosed. Sector not specified, limiting assessment of strategic implications.

17-02-2026

CPI Card Group Inc. filed an 8-K on 2026-02-17 (AccNo: 0001104659-26-015886, Size: 140 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, timing, or financial implications are explicitly stated in the provided filing summary. No quantitative metrics, performance comparisons, or other events are mentioned.

• ·Event date: 2026-02-17
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

17-02-2026

HireQuest, Inc. filed a Form 8-K on February 17, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This multi-item filing ensures broad dissemination of material non-public information and includes attached exhibits. No specific financial metrics, transaction details, positive or negative changes, or other quantitative data are disclosed in the provided filing information.

17-02-2026

Howmet Aerospace Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001104659-26-015914), reporting under Item 8.01 Other Events. No specific details regarding the nature of the other event, financial metrics, transactions, or scheduled events are disclosed in the provided filing information. Sector is not specified.

17-02-2026

Stabilis Solutions, Inc. filed a Form 8-K on February 17, 2026, under Item 2.02 for results of operations and financial condition, Item 7.01 for Regulation FD disclosure, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed. This is a multi-item filing announcing financial results with no detailed performance data provided.

17-02-2026

OMNIQ Corp. filed an 8-K on February 17, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the content of the Regulation FD disclosure, financial statements, exhibits, transactions, metrics, or events are disclosed in the provided filing information. This is a multi-item filing likely involving voluntary disclosure with supporting attachments.

17-02-2026

Masimo Corp filed a Form 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details provided on the agreement's nature, parties, terms, financial impacts, or any quantitative metrics such as transaction value, revenue effects, or guidance changes. No positive or negative metrics are disclosed, resulting in purely informational disclosure.

17-02-2026

VisionWave Holdings, Inc. filed a Form 8-K on 2026-02-17 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No details on the agreement terms, transaction value, financial impacts, strategic rationale, or any quantitative metrics are disclosed.

17-02-2026

BITMINE IMMERSION TECHNOLOGIES, INC. filed an 8-K on February 17, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing voluntarily disclosing material nonpublic information to comply with Regulation FD, with exhibits attached. No specific transaction details, financial metrics, positive or negative changes, or quantitative data are mentioned in the filing summary.

17-02-2026

Royal Caribbean Cruises Ltd filed a Form 8-K on February 17, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, reason for change, timing, or any quantitative metrics are provided.

17-02-2026

Kindly MD, Inc. filed a Form 8-K on February 17, 2026, reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided information. No positive or negative performance metrics are mentioned.

17-02-2026

Earth Science Tech, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on affected positions, individuals involved, reasons for the change, or any financial metrics are disclosed. No quantitative data, performance comparisons, or scheduled events are mentioned.

17-02-2026

Lite Strategy, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-053243), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item, voluntary filing typical for earnings announcements. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details.

17-02-2026

Global Business Travel Group, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001104659-26-015928, Size: 279 KB), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, or period-over-period comparisons are detailed in the filing information provided. This appears to be a standard earnings-related disclosure without quantified metrics.

17-02-2026

Sana Biotechnology, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or timing are explicitly stated. No quantitative data, performance metrics, or further governance implications are mentioned in the provided filing information.

• ·Accession Number: 0001193125-26-053294
• ·Filing size: 346 KB
• ·Event date aligns with filing date (2026-02-17), suggesting prompt disclosure within SEC 4-business-day requirement

17-02-2026

Chegg, Inc. filed an 8-K on February 17, 2026, reporting under Item 8.01 Other Events. No specific details regarding the nature of the event, financial metrics, transactions, or impacts are disclosed in the provided filing summary. All quantitative data and operational details are NOT_DISCLOSED.

17-02-2026

ServiceNow, Inc. filed an 8-K on February 17, 2026, specifically under Item 7.01 Regulation FD Disclosure. No quantitative financial metrics, transaction details, guidance changes, or operational data were explicitly stated in the filing information provided. The filing has Accession Number 0001373715-26-000014 and size of 141 KB, with sector not specified.

17-02-2026

Marriott Vacations Worldwide Corp filed an 8-K on February 17, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected officer's name, title, reason for departure or appointment, effective date, or internal/external status are disclosed. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the available information.

17-02-2026

Lakeland Industries Inc filed an 8-K on February 17, 2026, under Item 7.01 Regulation FD Disclosure (voluntary release of material nonpublic information) and Item 9.01 Financial Statements and Exhibits (attachments listed, such as press releases or presentations). No financial metrics, transaction details, guidance, or scheduled events are explicitly stated in the filing description. This is a multi-item, primarily voluntary disclosure with unknown specific content.

17-02-2026

Agassi Sports Entertainment Corp. filed an 8-K on February 17, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing indicating voluntary release of material information with attached exhibits, but specific details of the disclosure, events, financial metrics, or exhibits are NOT_DISCLOSED. No quantitative data, positive or negative metrics, transactions, or guidance changes are provided.

17-02-2026

XTI Aerospace, Inc. filed a Form 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.03 material modifications to rights of security holders, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed in the provided filing summary. This is a multi-item filing likely involving financing or restructuring with potential balance sheet and shareholder implications.

17-02-2026

Otter Tail Corp filed a Form 8-K on February 17, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, or guidance metrics are disclosed in the provided filing information. All quantitative financial details are NOT_DISCLOSED.

17-02-2026

VirTra, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-006967), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on key positions affected, individuals, appointment/resignation status, reasons, timing, or governance implications were provided. No quantitative data, financial metrics, or scheduled events were mentioned.

17-02-2026

SunCoke Energy, Inc. filed an 8-K on February 17, 2026, disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or directional performance data are detailed in the provided filing information. This appears to be a standard earnings-related disclosure with exhibits attached.

17-02-2026

PPLUS Trust Series GSC-2 filed a Form 8-K on February 17, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed. This is a multi-item voluntary filing with no quantitative metrics or directional impacts provided.

17-02-2026

CNL Healthcare Properties, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-053340, Size: 320 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on events, transactions, financial metrics, or quantitative data disclosed in the provided filing summary. No positive or negative metrics are mentioned.

17-02-2026

Xerox Holdings Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-053333), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or metrics provided in the filing summary. No quantitative data, period-over-period comparisons, or scheduled events are disclosed.

17-02-2026

Match Group, Inc. filed an 8-K on February 17, 2026 (AccNo: 0000891103-26-000022, Size: 162 KB), disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, timing, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.

• ·Filing date: 2026-02-17
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

17-02-2026

NRX Pharmaceuticals, Inc. filed a Form 8-K on February 17, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events or the contents of the exhibits are provided in the filing summary. This multi-item filing lacks quantitative metrics or directional indicators, resulting in no clear positive or negative implications.

17-02-2026

MDWerks, Inc. filed an 8-K on February 17, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also includes Item 7.01 for Regulation FD disclosure and Item 9.01 for financial statements and exhibits. Specific details including names, positions, reasons for changes, timing, or any quantitative data are NOT_DISCLOSED.

17-02-2026

Royale Energy, Inc. filed a Form 8-K on February 17, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with voluntary disclosure under Regulation FD, likely sharing previously selective information, accompanied by exhibits. No specific financial metrics, transactions, or performance data—positive or negative—are disclosed in the filing summary.

17-02-2026

NATIONAL HEALTHCARE CORP filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation status, reasons for change, timing, or any quantitative impacts were provided. No positive or negative metrics, governance implications, or board outcomes were mentioned.

17-02-2026

Trilogy Metals Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001279569-26-000134, Size: 245 KB), disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on financial results, but no specific revenue, earnings, balance sheet details, period-over-period comparisons, or other quantitative metrics are mentioned. No positive or negative performance indicators, guidance, or scheduled events are provided.

17-02-2026

C2 Blockchain, Inc. filed a Form 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 3.02 unregistered sales of equity securities. Item 9.01 provides financial statements and exhibits. No specific transaction values, parties, financial impacts, or other quantitative details are disclosed.

17-02-2026

Hugoton Royalty Trust filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-053624), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other financial metrics are disclosed in the provided filing information.

17-02-2026

SAN JUAN BASIN ROYALTY TRUST filed an 8-K on February 17, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, distributions, period-over-period changes, or other quantitative financial metrics are mentioned in the provided filing details. This appears to be a standard informational filing for operational results with no disclosed directional impacts.

17-02-2026

PermRock Royalty Trust filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-053670), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial details were disclosed in the provided filing summary. This is a standard informational disclosure for financial results without indicated positive or negative performance variations.

17-02-2026

Permian Basin Royalty Trust filed an 8-K on February 17, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing information.

17-02-2026

Marine Petroleum Trust filed an 8-K on February 17, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This appears to be a voluntary disclosure of material nonpublic information with attached exhibits. No financial metrics, transactions, or specific events are detailed in the provided filing summary.

17-02-2026

AMERICAN EXPRESS CO filed an 8-K on February 17, 2026 (AccNo: 0000004962-26-000102, Size: 221 KB) reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transaction details, period-over-period comparisons, or other quantitative data are explicitly stated in the provided filing information. This appears to be a single-item, voluntary disclosure with no directional implications discernible from the summary.

17-02-2026

SOUTHERN CO filed a Form 8-K on 2026-02-17 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, internal/external status, or timing are disclosed. No quantitative data, financial metrics, or other impacts are mentioned.

17-02-2026

17-02-2026

CROSS TIMBERS ROYALTY TRUST filed an 8-K on 2026-02-17 reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, distributions, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item, likely voluntary disclosure typical for financial results announcements.

• ·AccNo: 0001193125-26-054289
• ·File size: 88 KB

17-02-2026

Apple iSports Group, Inc. filed an 8-K on 2026-02-17 disclosing under Item 1.01 its entry into a material definitive agreement. No details regarding the nature of the agreement, counterparties, dollar value, financial terms, or strategic implications are provided in the filing summary. This is a single-item filing with no quantitative metrics, guidance changes, or scheduled events mentioned.

17-02-2026

Bluerock Homes Trust, Inc. filed an 8-K on February 17, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed in the filing summary. The filing size is 239 KB with Accession Number 0001104659-26-016316.

17-02-2026

Clearwater Analytics Holdings, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001866368-26-000004, Size: 158 KB), reporting solely under Item 7.01 Regulation FD Disclosure. This is a single-item voluntary filing with no specific details on the disclosed information, financial metrics, transactions, or events provided. No quantitative data, positive or negative metrics, or forward-looking statements are mentioned.

17-02-2026

17-02-2026

FIDUS INVESTMENT Corp filed an 8-K on February 17, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, transactions, financial metrics, or events are disclosed in the provided filing summary. This appears to be a voluntary disclosure with attached exhibits, but content is NOT_DISCLOSED.

17-02-2026

Eagle Point Income Co Inc. filed a Form 8-K on February 17, 2026, reporting under Item 8.01 Other Events. No specific details regarding the core event, financial metrics, transaction values, or quantitative data are disclosed in the provided filing information. This appears to be a single-item voluntary disclosure with unknown materiality.

17-02-2026

Mercury General Corp filed an 8-K on February 17, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or guidance details are disclosed in the filing information provided. This is an informational disclosure typical for quarterly or annual earnings releases.

17-02-2026

Rogers Corp filed a Form 8-K on 2026-02-17 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. This is a multi-item filing typical for earnings releases where specific quantitative metrics such as revenue, earnings, margins, or guidance are NOT_DISCLOSED in the provided information. No positive or negative performance indicators, period-over-period changes, or balance sheet effects are detailed.

17-02-2026

Goosehead Insurance, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details including the key position affected, appointment or resignation status, reasons, timing, and any financial metrics are NOT_DISCLOSED.

17-02-2026

Spartacus Acquisition Corp. II filed an 8-K on 2026-02-17 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, departures/elections/appointments of directors/officers under Item 5.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific deal parties, structure, valuation, financial metrics, synergies, or timelines were disclosed. Sector not specified.

17-02-2026

Beta Bionics, Inc. filed an 8-K on February 17, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing information. This is a multi-item filing focused on earnings release.

17-02-2026

HealthEquity, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001428336-26-000005, Size: 213 KB), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This is a standard voluntary earnings-related disclosure with no directional performance data available.

17-02-2026

Axcelis Technologies Inc filed an 8-K on 2026-02-17 under Item 2.02 disclosing Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This is a standard voluntary earnings-related disclosure with no period-over-period comparisons or directional performance indicators available.

17-02-2026

Portsmouth Square Inc filed a Form 8-K on February 17, 2026, specifically under Item 9.01: Financial Statements and Exhibits. No financial statements, exhibits, transaction details, metrics, or other material events are explicitly described in the provided filing information. This is an informational disclosure with no quantified impacts or directional implications disclosed.

17-02-2026

AIxCrypto Holdings, Inc. filed a Form 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No quantitative details, transaction values, financial impacts, or specific changes are provided in the filing summary.

17-02-2026

Nomadar Corp. filed an 8-K on February 17, 2026, reporting under Item 7.01 Regulation FD Disclosure, indicating voluntary release of material non-public information, and Item 9.01 Financial Statements and Exhibits, which attaches relevant documents. No specific transaction details, financial metrics, guidance, or quantitative impacts are disclosed in the filing summary. No positive or negative performance metrics are mentioned.

17-02-2026

Quantum Corp /DE/ filed an 8-K on February 17, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard voluntary earnings-related disclosure with no detailed performance data available.

• ·AccNo: 0001628280-26-008553
• ·File size: 473 KB
• ·Event Type: Financial Results
• ·Source: us_sec

17-02-2026

Medalist Diversified REIT, Inc. filed an 8-K on 2026-02-17 (AccNo: 0001104659-26-016379) disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers creation of a direct financial obligation (Item 2.03), material modifications to rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific transaction parties, values, terms, financial metrics, synergies, or impacts are detailed.

• ·Accession Number: 0001104659-26-016379
• ·Filing size: 1 MB
• ·Sector: not specified

17-02-2026

Coherus Oncology, Inc. filed an 8-K on 2026-02-17 disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the financial statements/exhibits were provided in the filing summary.

17-02-2026

Boston Beer Co Inc filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054573), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individual involved, reason for change, appointment or resignation status, timing, or any compensatory arrangements are disclosed. No quantitative data, financial metrics, or other changes are mentioned.

17-02-2026

MESA ROYALTY TRUST filed an 8-K on 2026-02-17 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, period-over-period changes, guidance, or other quantitative metrics are detailed in the provided filing information. The disclosure appears informational without extracted numerical impacts.

17-02-2026

INTERGROUP CORP filed a Form 8-K on February 17, 2026, reporting exclusively under Item 9.01 Financial Statements and Exhibits. No specific financial statements, exhibits, transaction details, or quantitative metrics are described in the provided filing summary. This is an informational disclosure with no apparent positive or negative financial impacts disclosed.

17-02-2026

Halozyme Therapeutics, Inc. filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, positive or negative metrics, or other quantitative data are disclosed in the provided filing information. This is a standard earnings-related disclosure, but detailed performance remains NOT_DISCLOSED.

17-02-2026

17-02-2026

P3 Health Partners Inc. filed a Form 8-K on February 17, 2026, disclosing under Item 1.01 its entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No details on the agreement's terms, parties, value, financial impacts, or strategic rationale are provided.

17-02-2026

Tactile Systems Technology Inc filed an 8-K on February 17, 2026, disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No quantitative financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other specific details are explicitly stated in the provided filing information. This appears to be a multi-item filing related to financial results announcement.

17-02-2026

RAVE RESTAURANT GROUP, INC. filed an 8-K on February 17, 2026, reporting changes in its certifying accountant under Item 4.01. Item 9.01 discloses financial statements and exhibits related to the change. No details on the accountants involved, reasons for the change, financial impacts, or other metrics are explicitly stated.

17-02-2026

Cadence Design Systems Inc filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative data are disclosed in the provided filing summary. This appears to be a standard mandatory earnings-related disclosure with attached financial statements.

17-02-2026

RB Global Inc. filed a Form 8-K on February 17, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing details. This multi-item filing is typical for earnings releases but lacks quantitative metrics or performance indicators.

17-02-2026

Solaris Energy Infrastructure, Inc. filed an 8-K on 2026-02-17 (AccNo: 0001193125-26-054550) disclosing officer changes under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, effective dates, or quantitative impacts are disclosed.

• ·Filing size: 237 KB
• ·Sector: not specified

17-02-2026

Yorkville Acquisition Corp. filed an 8-K on 2026-02-17 disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, and unregistered sales of equity securities under Item 3.02. Item 9.01 includes financial statements and exhibits. No quantitative metrics, deal terms, parties, or performance comparisons are disclosed, resulting in no identifiable positive or negative impacts.

17-02-2026

EXPAND ENERGY Corp filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a standard multi-item filing for financial results disclosure with no specific quantitative metrics, comparisons, or detailed outcomes provided in the filing summary. No positive or negative financial changes are disclosed.

17-02-2026

Castellum, Inc. filed a Form 8-K on February 17, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed.

17-02-2026

Innventure, Inc. filed an 8-K on February 17, 2026 (AccNo: 0002001557-26-000020, Size: 160 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific events, transactions, financial metrics, positive or negative changes, or quantitative data are detailed in the provided filing information. This appears to be a multi-item voluntary disclosure primarily for Reg FD compliance.

17-02-2026

AtriCure, Inc. filed an 8-K on February 17, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available for balanced analysis of positive or negative trends.

17-02-2026

BEL FUSE INC /NJ filed a Form 8-K on February 17, 2026 (AccNo: 0001437749-26-004366), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This discloses financial results, but specific revenue, earnings, balance sheet details, period-over-period changes, or other quantitative metrics are NOT_DISCLOSED in the provided information. No positive, negative, or flat performance indicators were explicitly stated.

17-02-2026

AST SpaceMobile, Inc. filed a multi-item 8-K on February 17, 2026, reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). While Items 1.01 and 2.03 suggest potential access to capital or financing, Item 3.02 indicates equity securities issuance that could dilute existing shareholders. No specific transaction values, terms, financial metrics, or impacts are disclosed.

17-02-2026

Armour Residential REIT, Inc. filed an 8-K on February 17, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, financial metrics, transactions, or exhibits are disclosed in the provided filing summary. This is a multi-item voluntary disclosure with no quantitative data or directional impacts mentioned.

17-02-2026

Q32 Bio Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-054711), reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing for Item 1.01, with no specific details on the agreement, events, transaction size, financial impacts, or metrics provided in the available information.

17-02-2026

Amrize Ltd filed an 8-K on February 17, 2026 (AccNo: 0002035989-26-000012), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, margins, or period-over-period comparisons in the available information. No positive or negative metrics, guidance, or strategic details are mentioned.

17-02-2026

Safe & Green Development Corp filed a Form 8-K on February 17, 2026, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This multi-item filing signals a significant transaction involving financing or partnership activity, but no specific dollar values, share counts, or financial impacts are disclosed. No positive or negative metrics are provided, resulting in no directional bias.

17-02-2026

Matador Resources Co filed an 8-K on February 17, 2026 (AccNo: 0001628280-26-008582, Size: 166 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with voluntary disclosure under Regulation FD, but specific details of the disclosed information, exhibits, financial metrics, transactions, or events are NOT_DISCLOSED. No positive or negative metrics, guidance changes, or impacts are mentioned.

• ·AccNo: 0001628280-26-008582
• ·Filing date: 2026-02-17

17-02-2026

Akamai Technologies Inc filed an 8-K on 2026-02-17 disclosing officer or director changes under Item 5.02, which covers departures, elections, appointments of certain officers or directors, and compensatory arrangements. Item 9.01 references financial statements and exhibits. No specific names, positions affected, reasons for change, or quantitative details provided.

• ·Sector: not specified
• ·Filing Accession Number: 0001086222-26-000004
• ·File Size: 231 KB

17-02-2026

Travelers Companies, Inc. filed an 8-K on February 17, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.

17-02-2026

TRUSTCO BANK CORP N Y filed an 8-K on February 17, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Specific details of the other events and the financial statements or exhibits are NOT_DISCLOSED. No quantitative metrics, transactions, or strategic implications are provided in the filing summary.

17-02-2026

BrightSpire Capital, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001717547-26-000005, Size: 10 MB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided filing information. Sector is not specified.

17-02-2026

Timken Co filed an 8-K on February 17, 2026, reporting under Item 8.01 Other Events, with accession number 0000098362-26-000017 and file size 163 KB. No specific details on the core event, transaction, financial metrics, or impacts are disclosed. This is a single-item voluntary disclosure with no quantitative data provided.

17-02-2026

Annexon, Inc. filed a Form 8-K on February 17, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names of individuals, positions affected, reasons for change, timing, or any quantitative compensation data are provided in the filing summary. This is a standard governance disclosure with no additional financial or operational metrics mentioned.

17-02-2026

LA-Z-BOY INC filed an 8-K on 2026-02-17 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases.

17-02-2026

Airship AI Holdings, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001654954-26-001312), under Item 2.02 disclosing results of operations and financial condition, Item 7.01 for Regulation FD disclosure, and Item 9.01 for financial statements and exhibits. This is a multi-item voluntary furnished filing typical for earnings pre-announcements, but no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed. No positive, negative, or flat metrics provided.

17-02-2026

Centerspace filed an 8-K on February 17, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet changes, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

17-02-2026

Quad/Graphics, Inc. filed an 8-K on 2026-02-17 disclosing changes related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data are disclosed in the provided filing summary.

17-02-2026

InPoint Commercial Real Estate Income, Inc. filed a Form 8-K on February 17, 2026, under Item 8.01 (Other Events), which is a voluntary disclosure category for company-determined material information. No specific details regarding the event, financial metrics, transactions, or impacts are disclosed in the provided filing metadata. This informational filing lacks quantitative data or directional indicators.

17-02-2026

JBG SMITH Properties filed an 8-K on February 17, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. This is a standard earnings-related disclosure for a real estate company. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are detailed in the filing description.

17-02-2026

ImageneBio, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054684), disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, effective dates, or financial details such as compensation amounts are disclosed in the provided information. No quantitative metrics, performance comparisons, or additional context provided.

17-02-2026

Palo Alto Networks Inc filed an 8-K on February 17, 2026 (AccNo: 0001327567-26-000003), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. Sector details are not specified.

17-02-2026

Devon Energy Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054657), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure with exhibits attached.

• ·Filing size: 860 KB
• ·Source: US SEC
• ·Sector: not specified

17-02-2026

TechPrecision Corp filed an 8-K on February 17, 2026 (AccNo: 0001104659-26-016425), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. All key financial data remains NOT_DISCLOSED.

17-02-2026

Howard Hughes Holdings Inc. filed a Form 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 1.02 termination of a prior material definitive agreement, representing a multi-item filing with mixed implications. Item 8.01 discloses other events, while Item 9.01 includes financial statements and exhibits. No specific details, transaction values, financial impacts, or quantitative metrics are disclosed.

17-02-2026

Orion S.A. filed an 8-K on 2026-02-17 disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or other financial metrics are mentioned. No positive or negative performance indicators, period-over-period comparisons, or operational details are provided in the filing summary.

17-02-2026

Skillz Inc. filed an 8-K on 2026-02-17 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key positions affected, names of individuals, reasons for the change, timing, or any quantitative data are provided in the filing summary. This appears to be an informational disclosure with no financial metrics or performance comparisons mentioned.

17-02-2026

Rush Enterprises Inc. (TX) filed a Form 8-K on February 17, 2026 (AccNo: 0001437749-26-004357), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for earnings releases, but specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED. No positive or negative performance indicators, period-over-period changes, or balance sheet details are provided in the available information.

17-02-2026

Veradigm Inc. filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed operational or financial data available.

• ·AccNo: 0001193125-26-054612
• ·File size: 699 KB
• ·Sector: not specified

17-02-2026

Glaukos Corp filed a Form 8-K on 2026-02-17 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided information. No positive or negative performance details, period-over-period comparisons, or balance sheet impacts are mentioned.

17-02-2026

SSR Mining Inc. filed a Form 8-K on February 17, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This constitutes a standard earnings-related disclosure with no directional performance indicators available.

17-02-2026

NATURAL HEALTH TRENDS CORP filed an 8-K on 2026-02-17 (AccNo: 0001437749-26-004352, Size: 247 KB) reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction value, parties, financial impacts, or metrics are disclosed. This is a multi-item mandatory filing with no period-over-period comparisons or quantitative data provided.

17-02-2026

Caesars Entertainment, Inc. filed an 8-K on February 17, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance changes are disclosed in the provided filing information. This represents a standard mandatory disclosure for quarterly or annual financial results with attached exhibits.

17-02-2026

AMERICAN ELECTRIC POWER CO INC filed an 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative impacts are disclosed. This appears to be a routine governance disclosure with no additional financial or operational metrics provided.

17-02-2026

Pitney Bowes Inc. filed an 8-K on February 17, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics were detailed in the provided filing information. The filing appears informational without directional financial indicators.

17-02-2026

Diamond Hill Investment Group Inc filed an 8-K on February 17, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are provided in the filing summary. No financial metrics, transactions, or directional impacts are disclosed.

17-02-2026

The Hackett Group, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-054765), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item, voluntary disclosure typical for quarterly financial results announcements. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing details.

17-02-2026

Star Holdings filed a Form 8-K on February 17, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached financials.

17-02-2026

FirstEnergy Corp filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure) for financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed financial data available.

17-02-2026

CORE MOLDING TECHNOLOGIES INC filed an 8-K on 2026-02-17 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific details on the agreement's nature, parties, value, financial impact, or strategic implications are provided.

17-02-2026

Element Solutions Inc filed an 8-K on 2026-02-17 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics are mentioned. This is an informational earnings-related disclosure without detailed performance data.

• ·AccNo: 0001590714-26-000017
• ·File size: 1 MB
• ·Sector: NOT_DISCLOSED

17-02-2026

Rockwell Automation, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054744), disclosing an officer change under Item 5.02 related to departures of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for change, or quantitative terms are disclosed.

17-02-2026

Luvu Brands, Inc. filed an 8-K on 2026-02-17 reporting the completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 provides financial statements and exhibits. No specific transaction details, financial metrics, parties involved, or values are disclosed.

17-02-2026

Advanced Micro Devices Inc. filed an 8-K on February 17, 2026 (AccNo: 0000002488-26-000029), disclosing information under Item 5.02 regarding departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are disclosed. This is a routine SEC-required disclosure for leadership changes with no additional quantitative or qualitative context provided.

17-02-2026

Ormat Technologies, Inc. filed an 8-K on February 17, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This multi-item filing includes voluntary disclosure of material nonpublic information previously communicated selectively and attached exhibits. No specific financial metrics, transactions, or quantitative data are disclosed in the filing summary.

17-02-2026

TPG RE Finance Trust, Inc. filed an 8-K on February 17, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, or period-over-period comparisons are disclosed in the provided filing information. Detailed quantitative metrics and guidance are NOT_DISCLOSED.

17-02-2026

Rush Street Interactive, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001793659-26-000003, Size: 543 KB), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing related to financial results, but specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are NOT_DISCLOSED in the provided information. No positive or negative metrics, strategic events, or scheduled follow-ups are mentioned.

17-02-2026

Andersons, Inc. filed an 8-K on February 17, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or other quantitative financial metrics were disclosed in the provided filing details. This is a standard disclosure for financial results with no mentioned positive or negative performance indicators.

17-02-2026

JELD-WEN Holding, Inc. filed a Form 8-K on February 17, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This multi-item filing provides no quantitative metrics, positive or negative performance indicators, or directional signals.

17-02-2026

ePlus Inc filed an 8-K on February 17, 2026, under Item 5.03 disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 references financial statements and exhibits. No quantitative details, financial impacts, or specifics on the amendments are provided.

17-02-2026

Hecla Mining Co/DE/ filed an 8-K on February 17, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details. Analysis is constrained by absence of detailed financial data.

17-02-2026

MetLife Inc filed an 8-K on February 17, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. This appears to be an informational filing with no quantified positive or negative impacts mentioned.

17-02-2026

NorthWestern Energy Group, Inc. filed a Form 8-K on 2026-02-17 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.

17-02-2026

Community Healthcare Trust Inc filed an 8-K on February 17, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, or other quantitative metrics were disclosed in the filing summary. This is a multi-item filing likely related to an earnings release.

17-02-2026

Simmons First National Corp filed a Form 8-K on February 17, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific other events, financial statements, exhibits, transaction values, metrics, or performance comparisons are disclosed in the provided filing information. This multi-item filing is informational with no quantified positive or negative impacts revealed.

17-02-2026

EQT Corp filed an 8-K on February 17, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other detailed results are disclosed in the provided filing information. This is a standard multi-item 8-K for financial results dissemination.

17-02-2026

MKS INC filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-054841), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a standard earnings-related disclosure, but no specific revenue, earnings, margins, guidance, or other quantitative metrics are provided in the filing summary. No positive or negative performance indicators, period-over-period changes, or strategic details are mentioned.

17-02-2026

Reborn Coffee, Inc. filed a Form 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected (e.g., CEO, CFO), individuals involved, appointment or resignation status, reasons for change, timing, or any quantitative data such as compensation amounts are disclosed. Sector is not specified.

17-02-2026

Huntsman CORP filed an 8-K on February 17, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure.

17-02-2026

bioAffinity Technologies, Inc. filed a Form 8-K on February 17, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with Accession Number 0001493152-26-007139 and file size 337 KB. No specific details on the events, transactions, financial impacts, or exhibits are disclosed in the provided filing summary.

17-02-2026

BullFrog AI Holdings, Inc. filed an 8-K on 2026-02-17 disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 9.01 includes Financial Statements and Exhibits. No additional financial metrics, reasons for delisting, or quantitative impacts are disclosed.

17-02-2026

Awaysis Capital, Inc. filed an 8-K on February 17, 2026, disclosing under Item 1.01 the entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 references financial statements and exhibits. No specific details on transaction terms, dollar values, strategic rationale, or financial impacts are disclosed.

17-02-2026

CBIZ, Inc. filed an 8-K on February 17, 2026, under Item 8.01 reporting Other Events. No specific details of the event, financial metrics, transaction values, or quantitative data were disclosed in the provided filing information. This is a single-item voluntary disclosure with no mentioned positive or negative impacts.

17-02-2026

DeFi Development Corp. filed an 8-K on February 17, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific details on the disclosed information, financial metrics, transactions, or exhibits are provided in the filing summary. This appears to be a voluntary informational disclosure with no quantified positive or negative impacts mentioned.

17-02-2026

Leslie's, Inc. filed an 8-K on February 17, 2026, under Item 2.02 reporting Results of Operations and Financial Condition. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.

17-02-2026

Apimeds Pharmaceuticals US, Inc. filed an 8-K on 2026-02-17 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing includes financial statements and exhibits under Item 9.01. No specific transaction details, parties, values, or financial impacts are disclosed.

17-02-2026

Mereo BioPharma Group plc filed a Form 8-K on 2026-02-17 under Item 3.01 announcing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing from the US market. No quantitative financial metrics, transaction values, or additional details such as revenue impacts, balance sheet effects, or guidance changes were disclosed.

17-02-2026

Atossa Therapeutics, Inc. filed an 8-K on 2026-02-17 under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, or additional details such as reasons for delisting, dollar impacts, or guidance changes were disclosed. This represents a material negative event with no offsetting positive information provided.

17-02-2026

Eos Energy Enterprises, Inc. filed a Form 8-K on 2026-02-17 reporting entry into a material definitive agreement under Item 1.01. Item 9.01 discloses financial statements and exhibits related to the agreement. No specific details on the agreement's parties, terms, value, financial impacts, or strategic context are provided.

17-02-2026

Kenvue Inc. filed an 8-K on February 17, 2026, reporting results of operations and financial condition under Item 2.02 alongside costs associated with exit or disposal activities under Item 2.05, indicating potential restructuring expenses. Financial statements and exhibits are included under Item 9.01. No specific financial metrics, performance comparisons, or impacts are disclosed in the provided filing summary.

17-02-2026

Lithium Americas Corp. filed an 8-K on 2026-02-17 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative metrics are provided. This appears to be a routine governance disclosure with no financial or performance data mentioned.

17-02-2026

Equity Bancshares Inc filed a Form 8-K on 2026-02-17 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), with Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event involving a new agreement and financial obligation. No quantitative details, transaction values, parties, impacts, or performance metrics (positive, negative, or flat) are disclosed.

• ·AccNo: 0001193125-26-054930
• ·File Size: 298 KB

17-02-2026

MEDIFAST INC filed an 8-K on 2026-02-17 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics were detailed in the provided filing information. This appears to be a standard earnings-related disclosure without extracted numerical data on performance.

17-02-2026

ARBOR REALTY TRUST INC filed an 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, names, reasons, or quantitative impacts are disclosed.

17-02-2026

WORLD ACCEPTANCE CORP filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation status, reasons, timing, or any financial metrics are disclosed.

17-02-2026

Falcon's Beyond Global, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the officer, position affected, reason for change, or any quantitative impacts are NOT_DISCLOSED.

17-02-2026

Terreno Realty Corp filed an 8-K on February 17, 2026, disclosing Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are provided. No quantitative financial data, transaction details, or performance metrics are mentioned.

17-02-2026

Celanese Corp filed an 8-K on February 17, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the filing summary. This is an informational earnings-related disclosure with no quantitative metrics available.

17-02-2026

Toll Brothers, Inc. filed an 8-K on February 17, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

17-02-2026

Empire State Realty OP, L.P. filed a Form 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific quantitative metrics such as revenue, earnings, or period-over-period changes in the available summary. No positive or negative performance indicators are detailed, resulting in purely informational disclosure.

17-02-2026

Inuvo, Inc. filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 references Financial Statements and Exhibits. No specific details on the agreement, transaction terms, financial impacts, or quantitative metrics are provided.

17-02-2026

CBL & Associates Properties Inc filed an 8-K on 2026-02-17 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were filed. No specific details on affected positions, individuals, reasons for change, or any quantitative metrics are disclosed.

17-02-2026

Beneficient filed an 8-K on February 17, 2026, reporting under Item 2.02 for Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet metrics, period-over-period changes, or quantitative financial data are disclosed in the provided filing details. This represents a standard voluntary earnings disclosure without detailed performance indicators.

17-02-2026

SAIA INC filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-055047, Size: 453 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific details on the disclosed information, financial metrics, transactions, or exhibits provided in the filing summary. No quantitative data, guidance, or events are mentioned.

17-02-2026

Aptiv PLC filed a Form 8-K on February 17, 2026, under Item 8.01 Other Events, which is a catch-all for material events not covered by other specific items. No details on the core event, financial impacts, transaction values, or operational metrics are explicitly stated in the provided filing information. All quantitative data and specifics are NOT_DISCLOSED.

17-02-2026

FingerMotion, Inc. filed an 8-K on February 17, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, positive or negative changes, or quantitative data are disclosed in the provided filing information.

17-02-2026

Digital Brands Group, Inc. filed a multi-item Form 8-K on February 17, 2026 (AccNo: 0001493152-26-007183), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No quantitative data, transaction details, financial impacts, or specific agreements are disclosed in the provided filing summary. Critical details such as dollar values, share counts, and strategic context remain NOT_DISCLOSED.

17-02-2026

United Acquisition Corp. I filed an 8-K on February 17, 2026, disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01. No specific details on deal structure, parties, valuation, financial metrics, synergies, or impacts are explicitly stated in the filing summary provided. Critical transaction information such as deal size, consideration, and timeline is NOT_DISCLOSED, limiting comprehensive analysis.

17-02-2026

17-02-2026

PSQ Holdings, Inc. filed a Form 8-K on 2026-02-17 under Accession No. 0001104659-26-016552 (297 KB), reporting a notice of delisting or failure to satisfy a continued listing rule or standard under Item 3.01. The multi-item filing also includes Item 2.02 on results of operations and financial condition and Item 9.01 for financial statements and exhibits. No specific financial metrics, reasons for delisting, transaction values, or quantitative impacts are disclosed.

17-02-2026

MarketAxess Holdings Inc filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-055003), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions, names of individuals, reasons for the change, effective dates, or any financial metrics are provided. No quantitative data, performance comparisons, or other material impacts are mentioned.

17-02-2026

Civista Bancshares, Inc. filed a Form 8-K on February 17, 2026, reporting under Item 5.08 regarding shareholder nominations pursuant to Exchange Act Rule 14a-11 and under Item 8.01 other events. No quantitative financial metrics, transaction values, or performance comparisons were disclosed. This is a multi-item procedural filing with no indicated positive or negative impacts.

17-02-2026

Bayview Acquisition Corp filed an 8-K on 2026-02-17 under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No quantitative financial metrics, deal structure details, parties involved, or merger/acquisition specifics are disclosed in the filing summary. Sector is not specified.

17-02-2026

Carpenter Technology Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054998, Size: 156 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, individual names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

17-02-2026

Andretti Acquisition Corp. II filed an 8-K on 2026-02-17 disclosing the termination of a material definitive agreement under Item 1.02. The filing also references financial statements and exhibits under Item 9.01. No specific details on the agreement parties, terms, financial impacts, or other metrics are provided.

17-02-2026

Elite Pharmaceuticals Inc. /NV/ filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-007190), disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing typical for earnings releases, but no specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided information. Sector is not specified.

17-02-2026

GREAT SOUTHERN BANCORP, INC. filed a Form 8-K on February 17, 2026 (AccNo: 0001171843-26-000861, size: 218 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed. This appears to be a multi-item informational filing with no quantified metrics or directional impacts provided.

17-02-2026

PPL Corp filed a Form 8-K on February 17, 2026 (AccNo: 0000922224-26-000004, Size: 264 KB) reporting under Item 8.01 Other Events. No specific details regarding the nature of the events, financial impacts, transactions, or metrics are disclosed in the provided filing information. No positive or negative metrics are mentioned.

17-02-2026

HOOKER FURNISHINGS Corp filed an 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial metrics, or impacts are disclosed in the provided filing summary. This is a multi-item mandatory disclosure.

17-02-2026

Ovintiv Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-055088, Size: 198 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or directional information are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure with attached exhibits.

17-02-2026

Redwire Corp filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or compensatory arrangements are disclosed. No quantitative financial metrics, performance comparisons, or other material data are provided.

17-02-2026

Auddia Inc. filed a Form 8-K on 2026-02-17 reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details, terms, financial metrics, or quantitative impacts disclosed in the provided information. No positive or negative metrics are mentioned.

17-02-2026

Healthy Choice Wellness Corp. filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. No specific transaction details, dollar values, share counts, or financial impacts are disclosed. This is a multi-item filing with no period-over-period metrics or comparisons provided.

17-02-2026

17-02-2026

Dorchester Minerals, L.P. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any named individuals are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are provided in the filing summary.

17-02-2026

DIRTT Environmental Solutions Ltd filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-055157), reporting entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, and Regulation FD disclosure under Item 7.01. This is a multi-item filing with no specific transaction details, financial metrics, dollar values, or named individuals disclosed. No positive or negative performance metrics were provided, preventing assessment of directional impact.

17-02-2026

GENCO SHIPPING & TRADING LTD filed a Form 8-K on February 17, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are mentioned in the provided filing information. This is a voluntary disclosure of financial results with no extracted positive or negative performance indicators.

17-02-2026

Chemung Financial Corp filed an 8-K on February 17, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the nature of the other events or contents of the exhibits disclosed in the provided information. No financial metrics, transactions, or directional impacts are mentioned.

17-02-2026

CIMG Inc. filed a Form 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, and under Item 3.02 unregistered sales of equity securities. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, share counts, or financial impacts are disclosed.

• ·Multi-item 8-K filing (Items 1.01, 2.03, 3.02, 9.01)

17-02-2026

EXICURE, INC. filed an 8-K on 2026-02-17 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed. This is an informational governance event with no additional performance or financial data provided.

17-02-2026

Bally's Corp filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, transaction terms, dollar values, or financial impacts are disclosed.

17-02-2026

GeoVax Labs, Inc. filed an 8-K on February 17, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02. Regulation FD disclosure is provided under Item 7.01, accompanied by financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period metrics are disclosed.

17-02-2026

Valaris Ltd filed an 8-K on February 17, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, metrics, transactions, or content of the disclosure or exhibits are disclosed in the provided filing information.

17-02-2026

Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-007204), reporting under Item 2.02 for Results of Operations and Financial Condition. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were disclosed in the provided filing information. This appears to be a single-item, mandatory disclosure typical for financial results announcements.

17-02-2026

Klotho Neurosciences, Inc. filed an 8-K on February 17, 2026, under Item 5.07 reporting the submission of matters to a vote of security holders, typically disclosing results from a shareholder meeting. Item 9.01 discloses financial statements and exhibits. No specific vote results, proposals, financial metrics, or exhibit details are provided in the filing summary.

17-02-2026

Steel Dynamics Inc filed an 8-K on February 17, 2026 (AccNo: 0001104659-26-016583, size: 222 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transactions, guidance, or events are disclosed in the filing metadata. This is a multi-item informational filing with no directional data provided.

17-02-2026

AirJoule Technologies Corp. filed an 8-K on February 17, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or terms are disclosed.

17-02-2026

Select Water Solutions, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001140361-26-005834), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative data are disclosed in the provided filing information. This is an informational earnings release filing with no detailed performance indicators available.

• ·Filing size: 1 MB
• ·Accession Number: 0001140361-26-005834